Access Vascular
Bedford
About Access Vascular
Access Vascular has developed a disruptive technology using a novel material process intended to significantly reduce the blood component accumulation (thrombosis or blood clotting) that leads to occlusions and infections. Over the last three years, Access Vascular’s technology has demonstrated the potential for superior clinical outcomes and lower healthcare costs compared with existing technologies. For patients, their solutions are predicted to decrease morbidity, shorten hospital stays, advance treatment, and minimize pain. Their technology has the potential to address a range of clinical needs in a variety of indications. Access Vascular is focused initially on launching their HydroPICC, a peripherally inserted central catheter with superior material performance over the current lagging technology.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $57.1M
- Funding stage: Late Stage Venture
- Last round: Series C (Oct 2023)
- Website: accessvascularinc.com
- Phone: +1 781 538 6594
Industries & Categories
Advanced Materials, Health Care, Manufacturing, Medical Device, Product Management
Social Profiles
Canonical: https://fsome.com/organization/access-vascular-52517 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.